Home
>
National Drug Code (NDC)
>
Methyldopa
Methyldopa - 0093-2931-01 - (Methyldopa)
Drug Information of Methyldopa
| Product NDC: | 0093-2931 |
| Proprietary Name: | Methyldopa |
| Non Proprietary Name: | Methyldopa |
| Active Ingredient(s): | 250 mg/1 & nbsp; Methyldopa |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Methyldopa
| Product NDC: | 0093-2931 |
| Labeler Name: | Teva Pharmaceuticals USA Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA070098 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20090223 |
Package Information of Methyldopa
| Package NDC: | 0093-2931-01 |
| Package Description: | 100 TABLET, FILM COATED in 1 BOTTLE (0093-2931-01) |
NDC Information of Methyldopa
| NDC Code | 0093-2931-01 |
| Proprietary Name | Methyldopa |
| Package Description | 100 TABLET, FILM COATED in 1 BOTTLE (0093-2931-01) |
| Product NDC | 0093-2931 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Methyldopa |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20090223 |
| Marketing Category Name | ANDA |
| Labeler Name | Teva Pharmaceuticals USA Inc |
| Substance Name | METHYLDOPA |
| Strength Number | 250 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] |
